StockNews.com Begins Coverage on NantHealth (NASDAQ:NH)
StockNews.com Begins Coverage on NantHealth (NASDAQ:NH)
StockNews.com initiated coverage on shares of NantHealth (NASDAQ:NH – Get Rating) in a report issued on Thursday morning. The firm issued a hold rating on the stock.
StockNews.com開始報道以下公司的股票 NantHealth(納斯達克股票代碼:NH — 獲取評級) 在週四上午發佈的一份報告中。該公司對該股發佈了持有評級。
NantHealth Stock Performance
NanHealth 股票表現
Shares of NH stock opened at $1.77 on Thursday. The stock has a market cap of $13.64 million, a PE ratio of -0.23 and a beta of 1.82. NantHealth has a 1 year low of $1.57 and a 1 year high of $11.85. The stock has a fifty day moving average price of $2.71 and a 200 day moving average price of $1.84.
NH股票週四開盤價爲1.77美元。該股的市值爲1,364萬美元,市盈率爲-0.23,beta值爲1.82。NantHealth的1年低點爲1.57美元,爲1年來的最高水平,爲11.85美元。該股的五十天移動平均價格爲2.71美元,200天移動平均價格爲1.84美元。
Institutional Inflows and Outflows
機構流入和流出
Several institutional investors have recently added to or reduced their stakes in NH. Goldman Sachs Group Inc. acquired a new stake in NantHealth during the second quarter worth approximately $36,000. Millennium Management LLC acquired a new stake in shares of NantHealth during the second quarter worth $110,000. Finally, Atria Wealth Solutions Inc. boosted its holdings in shares of NantHealth by 117.7% during the second quarter. Atria Wealth Solutions Inc. now owns 491,942 shares of the company's stock worth $205,000 after purchasing an additional 265,949 shares during the last quarter. Institutional investors and hedge funds own 4.50% of the company's stock.
一些機構投資者最近增加了或減少了在新罕布什爾州的股份。高盛集團公司在第二季度收購了NanThealth的新股份,價值約36,000美元。千禧管理有限責任公司在第二季度收購了價值11萬美元的NanThealth股票的新股份。最後,Atria Wealth Solutions Inc.在第二季度將其持有的NantHealth股票增加了117.7%。Atria Wealth Solutions Inc. 在上個季度又購買了265,949股股票後,現在擁有該公司491,942股股票,價值20.5萬美元。機構投資者和對沖基金擁有該公司4.50%的股票。
About NantHealth
關於 nanHealth
(Get Rating)
(獲取評分)
NantHealth, Inc is an evidence-based, personalized healthcare company, which engages in the provision of treatment for critical diseases such as cancer. The firm empowers treatment decisions, improves patient outcomes, validates treatment options, enables high-quality care, lowers costs, ensures appropriate reimbursement, and streamlines implementation and deployment.
NantHealth, Inc是一家基於證據的個性化醫療保健公司,致力於爲癌症等關鍵疾病提供治療。該公司支持治療決策,改善患者預後,驗證治療方案,提供高質量的護理,降低成本,確保適當的報銷,並簡化實施和部署。
Read More
閱讀更多
- Get a free copy of the StockNews.com research report on NantHealth (NH)
- MarketBeat Week in Review – 4/3 – 4/7
- Costco Sales Disappoint, Markets Are Missing This Upside Driver
- First Republic Bank Is A Speculative Play, Here's Why
- The WD-40 Company Bottoms With Reversal In Sight
- 3 Low-Cost Stock ETFs That Are Crushing It This Year
- 免費獲取 StockNews.com 關於 NantHealth(NH)的研究報告的副本
- MarketBeat 一週回顧 — 4/3 — 4/7
- 好市多的銷售令人失望,市場缺少這種上行驅動力
- 第一共和國銀行是投機遊戲,原因如下
- WD-40 公司觸底,逆轉在眼前
- 今年有3只低成本股票ETF大放異彩了
Receive News & Ratings for NantHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NantHealth and related companies with MarketBeat.com's FREE daily email newsletter.
接收 NanHealth Daily 的新聞和收視率 -在下面輸入您的電子郵件地址,通過Marketbeat.com的免費每日電子郵件時事通訊接收NantHealth及相關公司最新新聞和分析師評級的簡明每日摘要。